These systems will improve the glycemic control of the patient and reduce the risk of hypoglycemia and hyperglycemia, ultimately enhancing the quality of life of patients, especially those that suffer from T1D and other insulin-dependent conditions [1,2]. The gene discussed is INS; the disease is type 1 diabetes mellitus.